logo
Plus   Neg
Share
Email

Altria To Discontinue Certain E-Vapor Products; To Take $200 Mln Charge In Q4

Altria Group Inc. (MO) said that it will discontinue production and distribution of all MarkTen and Green Smoke e-vapor products and VERVE oral nicotine containing products. The decision is based upon the current and expected financial performance of these products, coupled with regulatory restrictions that burden Altria's ability to quickly improve these products.

The company noted that it will refocus its resources on more compelling reduced-risk tobacco product opportunities.

Altria noted that its subsidiaries will begin working with their retailers, wholesalers, contract manufacturers and suppliers to ensure an orderly process. MarkTen cig-a-likes are currently in distribution at retail and through e-commerce. Green Smoke is primarily available on e-commerce with limited retail presence. VERVEis in limited distribution at retail and e-commerce.

Altria expects to record one-time pre-tax charges of approximately $200 million, the majority of which would be non-cash asset impairment charges, in the fourth quarter of 2018 as a result of this decision. These charges will be excluded from Altria's adjusted result.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
AT&T Inc. (T) reported first-quarter adjusted earnings per share of $0.86 compared to $0.85, prior year. On average, 23 analysts polled by Thomson Reuters expected the company to report profit per share of $0.86 for the quarter. Analysts' estimates typically exclude special items. Adjusting for amortization,... Shares of Credit Suisse Group AG were gaining around 3 percent in Swiss trading after the banking major reported Wednesday higher profit in its first quarter, despite weak revenues. Looking ahead, the company said it is cautiously optimistic about its prospects for the second quarter of 2019. The company remains focused on increasing its returns over the course of 2019 and beyond. While reporting financial results for the first quarter, Thermo Fisher Scientific Inc. (TMO) on Wednesday raised its adjusted earnings and revenue guidance for the full year 2019 to reflect strong operational performance and the acquisition of Brammer Bio, partially offset by a more adverse foreign exchange...
Follow RTT